eprex 2000 i.j./0.5 ml otopina za injekciju u napunjenoj štrcaljki
inpharm co. d.o.o. banja luka - epoetin alfa - otopina za injekciju u napunjenoj štrcaljki - 2000 i.j./0.5 ml - 0,5 ml otopine za injekciju u napunjenoj štrcaljki sadrži: 2000 i.j epoetin alfa (humani rekombinantni eritropoetin)
binocrit 2000 i.j./1 ml rastvor za injekciju u napunjenoj šprici
novartis ba d.o.o. - epoetin alfa - rastvor za injekciju u napunjenoj šprici - 2000 i.j./1 ml - 1 ml rastvora za injekciju u napunjenoj šprici sadrži: 2000 i.j. epoetin alfa
binocrit 40000 i.j./1 ml rastvor za injekciju u napunjenoj šprici
novartis ba d.o.o. - epoetin alfa - rastvor za injekciju u napunjenoj šprici - 40000 i.j./1 ml - 1 ml rastvor za injekciju u napunjenoj šprici sadrži: 40000 i.j. epoetin alfa
binocrit 40000 i.j./1 ml rastvor za injekciju u napunjenoj šprici
novartis ba d.o.o. - epoetin alfa - rastvor za injekciju u napunjenoj šprici - 40000 i.j./1 ml - 1 ml rastvora za injekciju u napunjenoj šprici sadrži: 40000 i.j. epoetin alfa
pegasys 180 µg/0.5 ml rastvor za injekciju u napunjenom špricu
roche d.o.o.roche ltd. - peginterferon alfa2a - rastvor za injekciju u napunjenom špricu - 180 µg/0.5 ml - 0,5 ml rastvora za injekciju u napunjenoj šprici sadrži: 180 mcg peginterferon alfa2a
humira 40 mg/0.4 ml rastvor za injekciju u napunjenoj šprici
abbvie d.o.o. - adalimumab - rastvor za injekciju u napunjenoj šprici - 40 mg/0.4 ml - 0,4 ml rastvora za injekciju u napunjenoj šprici sadrži: 40 mg adalimumaba
xados 10 mg/1 tableta oralna disperzibilna tableta
berlin chemie / menarini bh d.o.o. sarajevo - bilastin - oralna disperzibilna tableta - 10 mg/1 tableta - 1 oralna disperzibilna tableta sadrži: 10 mg bilastina
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
xados 2,5 mg/1 ml oralna otopina
berlin chemie / menarini bh d.o.o. sarajevo - bilastin - oralna otopina - 2,5 mg/1 ml - 1 ml oralne otopine sadrži: 2,5 mg bilastina
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastična sredstva - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.